Zynrelef

Active Ingredient(s): Bupivacaine + Meloxicam
FDA Approved: * May 12, 2021
Pharm Company: * Heron Therapeutics, Inc.
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zynrelef Overview

Bupivacaine/meloxicam, sold under the brand name Zynrelef, is a fixed-dose combination medication used to treat pain in small to medium-sized wounds after surgery.[1][2] It contains bupivacaine and meloxicam.[1][2] The most common side effects of bupivacaine/meloxicam are dizziness, constipation, vomiting, and headache.[1][2] It was approved for medical use in the European Union in September 2020,&...

Read more Zynrelef Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bupivacaine/meloxicam

Recent Zynrelef Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bupivacaine + Meloxicam
  • Solution: 200mg/6mg, 300mg/9mg, 400mg/12mg, 60mg/1.8mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (22 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 June 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA